We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+6.14%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.7B
AUM Growth
+$669M
Cap. Flow
+$101M
Cap. Flow %
0.79%
Top 10 Hldgs %
53.96%
Holding
1,032
New
51
Increased
303
Reduced
597
Closed
72

Sector Composition

Rank Sector Weight
1 Energy 65.53%
2 Technology 4.85%
3 Healthcare 3.53%
4 Consumer Discretionary 3.46%
5 Financials 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WLY icon
526
John Wiley & Sons Class A
WLY
$2.59B
$821K 0.01%
25,853
-1,644
-6% -$51.4K
OPK icon
527
Opko Health
OPK
$936M
$810K 0.01%
+536,481
New +$776K
DOV icon
528
Dover
DOV
$27.7B
$808K 0.01%
5,250
-1,350
-20% -$189K
NTES icon
529
NetEase
NTES
$79.2B
$807K 0.01%
8,665
-1,390
-14% -$148K
ODFL icon
530
Old Dominion Freight Line
ODFL
$47.2B
$802K 0.01%
3,956
+20
+0.5% +$3.97K
DCPH
531
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$802K 0.01%
49,699
-8,516
-15% -$109K
POR icon
532
Portland General Electric
POR
$5.93B
$800K 0.01%
18,459
+2,603
+16% +$108K
CTRA
533
DELISTED
Coterra Energy
CTRA
$800K 0.01%
31,346
-1,919
-6% -$51.4K
LRCX icon
534
Lam Research
LRCX
$365B
$800K 0.01%
10,210
-160
-2% -$10.9K
DOX icon
535
Amdocs
DOX
$5.64B
$798K 0.01%
9,076
-183
-2% -$15.2K
NJR icon
536
New Jersey Resources
NJR
$6.01B
$795K 0.01%
17,842
+2,496
+16% +$106K
SLNO
537
DELISTED
Soleno Therapeutics
SLNO
$784K 0.01%
+19,486
New +$554K
KROS icon
538
Keros Therapeutics
KROS
$202M
$780K 0.01%
19,612
-2,281
-10% -$71.5K
DG icon
539
Dollar General
DG
$27.2B
$775K 0.01%
5,698
+27
+0.5% +$3.27K
SNAP icon
540
Snap
SNAP
$7.6B
$763K 0.01%
45,056
-27,529
-38% -$338K
VRDN icon
541
Viridian Therapeutics
VRDN
$2.18B
$759K 0.01%
34,854
+2,592
+8% +$40.9K
CGBD icon
542
Carlyle Secured Lending
CGBD
$710M
$758K 0.01%
50,700
-1,100
-2% -$16K
GERN icon
543
Geron
GERN
$949M
$757K 0.01%
358,782
-27,518
-7% -$53.5K
ALPN
544
DELISTED
Alpine Immune Sciences Inc
ALPN
$755K 0.01%
+39,591
New +$550K
HBNC icon
545
Horizon Bancorp
HBNC
$1.05B
$747K 0.01%
52,209
-3,322
-6% -$37.5K
PLRX icon
546
Pliant Therapeutics
PLRX
$66.9M
$744K 0.01%
41,062
-3,117
-7% -$47.4K
KNSA icon
547
Kiniksa Pharmaceuticals
KNSA
$4.89B
$735K 0.01%
41,896
-29,207
-41% -$480K
MP icon
548
MP Materials
MP
$7.68B
$732K 0.01%
36,893
+14,231
+63% +$243K
AMLX icon
549
Amylyx Pharmaceuticals
AMLX
$2.17B
$732K 0.01%
49,728
+32
+0.1% +$490
DVN icon
550
Devon Energy
DVN
$49.8B
$729K 0.01%
16,092
-429,454
-96% -$19.7M

Similar funds

ALPS Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, ALPS Advisors held 1,032 positions worth $12.7B, up 5.5% from $12B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

ALPS Advisors's Q4 2023 filing shows 51 new, 303 increased, 597 reduced and 72 closed positions. Its largest new stake was Sunoco: 9,498,706 shares worth $569M. The largest sale was Crestwood Equity Partners LP, an estimated $443M.

By sector, the portfolio is most concentrated in Energy at 66% of assets, down from 68% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q4 2023 buy was Sunoco: 9,498,706 shares worth $569M.
  • ALPS Advisors added most to Cameco in Q4 2023, an estimated $34.4M increase.
  • ALPS Advisors's biggest Q4 2023 reduction was MPLX, cutting an estimated $114M.
  • ALPS Advisors fully exited Crestwood Equity Partners LP in Q4 2023, selling an estimated $443M.
  • ALPS Advisors's ten largest holdings make up 54% of its $12.7B portfolio in Q4 2023.
  • ALPS Advisors opened 51 new positions and closed 72 in Q4 2023.
  • ALPS Advisors's portfolio value rose 5.5% quarter-over-quarter to $12.7B.

Based on ALPS Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.